Suppr超能文献

印度尼西亚儿童中重症新型冠状病毒肺炎多系统炎症综合征与重症登革热的对比:一项横断面研究。

Severe COVID-19 multisystem inflammatory syndrome versus severe dengue in children from Indonesia: a cross-sectional study.

作者信息

Alam Anggraini, Andriyani Fina Meilyana, Peryoga Stanza Uga

机构信息

Infection & Tropical Diseases Division, Department of Child Health, Faculty of Medicine, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung, Indonesia.

Emergency and Intensive Care Division, Department of Child Health, Faculty of Medicine, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung, Indonesia.

出版信息

Int J Emerg Med. 2024 Jul 11;17(1):85. doi: 10.1186/s12245-024-00658-6.

Abstract

INTRODUCTION

Severe multisystem inflammatory syndrome in children (MIS-C) and severe dengue are challenging to identify during the COVID-19 pandemic in dengue-endemic areas. Fever, multiorgan involvement, and shock characterize both severe MIS-C and severe dengue. Distinguishing between the two diseases is beneficial in initiating proper management.

METHODS

Medical records of children < 18 years old who were hospitalized at Hasan Sadikin General Hospital's PICU between December 2020 and July 2022 with severe MIS-C or severe dengue were recorded. Differences were assessed using comparative and descriptive analyses.

RESULTS

Seventeen severe dengue patients and 4 severe MIS-C were included. The average age of severe MIS-C was 11.5 years (SD ± 2.9, 95% CI), and that of severe dengue patients was 6.2 years (SD ± 4.4, 95% CI) (p value = 0.034, 95%). Fever and abdominal pain were the most common symptoms in both groups (p = 0.471, 95% CI). Rash (p = 0.049) and nonpurulent conjunctivitis (p = 0.035) were two symptoms with significant differences. The highest platelet count (p-value = 0.006, 95% CI), AST (p-value = 0.026, 95% CI), and D-dimer level (p-value = 0.025, 95% CI) were significantly different between the two cohorts. Cardiac abnormalities were found in all (100%) severe MIS-C patients, but only one (5.9%) in severe dengue patients.

CONCLUSION

Age, rash, nonpurulent conjunctivitis, platelet count, AST and D-dimer level may distinguish severe MIS-C from severe dengue fever.

摘要

引言

在登革热流行地区的新冠疫情期间,儿童严重多系统炎症综合征(MIS-C)和严重登革热难以鉴别。严重MIS-C和严重登革热均以发热、多器官受累及休克为特征。区分这两种疾病有助于开展恰当的治疗。

方法

记录2020年12月至2022年7月期间在哈桑·萨迪金综合医院儿科重症监护病房住院的18岁以下患有严重MIS-C或严重登革热的儿童的病历。采用比较分析和描述性分析评估差异。

结果

纳入17例严重登革热患者和4例严重MIS-C患者。严重MIS-C患者的平均年龄为11.5岁(标准差±2.9,95%置信区间),严重登革热患者的平均年龄为6.2岁(标准差±4.4,95%置信区间)(p值 = 0.034,95%)。发热和腹痛是两组最常见的症状(p = 0.471,95%置信区间)。皮疹(p = 0.049)和非脓性结膜炎(p = 0.035)是两种有显著差异的症状。两组之间最高血小板计数(p值 = 0.006,95%置信区间)、谷草转氨酶(p值 = 0.026,95%置信区间)和D-二聚体水平(p值 = 0.025,95%置信区间)有显著差异。所有(100%)严重MIS-C患者均发现心脏异常,而严重登革热患者中只有1例(5.9%)有心脏异常。

结论

年龄、皮疹、非脓性结膜炎、血小板计数、谷草转氨酶和D-二聚体水平可能有助于区分严重MIS-C和严重登革热。

相似文献

3
Comparison of Multisystem Inflammatory Syndrome (MIS-C) and Dengue in Hospitalized Children.
Indian J Pediatr. 2023 Jul;90(7):654-659. doi: 10.1007/s12098-022-04184-2. Epub 2022 May 5.
5
Severe Dengue With Multisystem Inflammatory Syndrome in Children Due to COVID-19: A Co-infection Case Series.
Cureus. 2021 Nov 12;13(11):e19516. doi: 10.7759/cureus.19516. eCollection 2021 Nov.
7
Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.
Clin Rheumatol. 2021 Aug;40(8):3227-3237. doi: 10.1007/s10067-021-05631-9. Epub 2021 Feb 12.

引用本文的文献

本文引用的文献

1
Clinical Presentation and Management of Multisystem Inflammatory Syndrome in Children With COVID-19: A Systematic Review.
Cureus. 2023 Oct 12;15(10):e46918. doi: 10.7759/cureus.46918. eCollection 2023 Oct.
2
The role of angiotensin-converting enzyme 2 () genetic variations in COVID-19 infection: a literature review.
Egypt J Med Hum Genet. 2022;23(1):97. doi: 10.1186/s43042-022-00309-6. Epub 2022 May 28.
3
Antimicrobial Stewardship in Tropical Infectious Diseases: Focusing on Dengue and Malaria.
Trop Med Infect Dis. 2022 Jul 30;7(8):159. doi: 10.3390/tropicalmed7080159.
4
Severe Thrombocytopenia Associated with Dengue Fever: An Evidence-Based Approach to Management of Thrombocytopenia.
Case Rep Hematol. 2022 Aug 12;2022:3358325. doi: 10.1155/2022/3358325. eCollection 2022.
5
Risk factors for multisystem inflammatory syndrome in children - A population-based cohort study of over 2 million children.
Lancet Reg Health Eur. 2022 Aug;19:100443. doi: 10.1016/j.lanepe.2022.100443. Epub 2022 Jun 22.
6
Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents.
Crit Care Clin. 2022 Jul;38(3):571-586. doi: 10.1016/j.ccc.2022.01.005. Epub 2022 Jan 10.
7
Multisystem Inflammatory Syndrome in Children (MIS-C).
Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22.
8
Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study.
Ital J Pediatr. 2022 Feb 8;48(1):25. doi: 10.1186/s13052-021-01189-z.
10
Dengue and the heart.
Cardiovasc J Afr. 2021;32(5):276-283. doi: 10.5830/CVJA-2021-033. Epub 2021 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验